What is Tarsus Pharmaceuticals, Inc.'s prepaid expenses?

Tarsus Pharmaceuticals, Inc. (TARS) reported prepaid expenses of $26.72M in Q1 2026.

How has Tarsus Pharmaceuticals, Inc.'s prepaid expenses changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s prepaid expenses increased by 345.4% year-over-year, from $6M to $26.72M.

What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s prepaid expenses?

Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s prepaid expenses has grown at a 40.2% compound annual growth rate (CAGR), from $2.49M to $13.47M.

Tarsus Pharmaceuticals, Inc. TARS Prepaid expenses

Prepaid expenses at other companies

StrykerSYK

$1.38B-10.6%

Hecla MiningHL

$28.04M+11.3%

Ryder SystemR

$372M+5.7%

Paymentus HoldingsPAY

$3.87M+52.5%

Edwards LifesciencesEW

$135.7M+21.9%

Life Time Group HoldingsLTH

$80.32M+38.5%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s prepaid expenses?: Tarsus Pharmaceuticals, Inc. (TARS) reported prepaid expenses of $26.72M in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s prepaid expenses changed year-over-year?: Tarsus Pharmaceuticals, Inc.'s prepaid expenses increased by 345.4% year-over-year, from $6M to $26.72M.
What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s prepaid expenses?: Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s prepaid expenses has grown at a 40.2% compound annual growth rate (CAGR), from $2.49M to $13.47M.